Cognitive function

RCT supports efficacy of St John’s wort for postmenopausal symptoms and depression

19-Sep-2019 By Stephen Daniells

Supplements of St John’s wort may help reduce the incidence of hot flashes and help depression in postmenopausal women, says a new study.

Ayurveda and Alzheimer’s: Bacosides from Brahmi display cognitive benefits– Malaysian review

18-Sep-2019 By Tingmin Koe

The Ayurvedic herb, bacopa monnieri (B monnieri), has shown to protect against Alzheimer’s disease (AD), according to a new scientific review.

Hemp producer signs UFC deal in fiscal year that saw sales soar 349%

16-Sep-2019 By Hank Schultz

Hemp/CBD player Aurora Cannabis announced a huge gain in sales in a fiscal year that saw the company sign a ‘research partnership’ with the UFC, a combat sports league.

‘Top-tier evidence’: Major Australian meta-review backs EPA for improving mental health

16-Sep-2019 By Tingmin Koe

Polyunsaturated fatty acids (PUFAs), and in particular eicosapentaenoic acid (EPA), has shown the strongest evidence for improving cognitive disorders, such as depression, according to a meta-review.

RCT supports bioavailability of lutein from novel water-soluble formulation

13-Sep-2019 By Stephen Daniells

The bioavailability of lutein may be enhanced by using a water-soluble formulation, according to a new study from Taiyo using its Sunactive LT ingredient.

Choline must be integrated into the prenatal supplement regimen, says expert review

11-Sep-2019 By Stephen Daniells

The importance of choline during the first 1,000 days after conception is increasingly understood by the medical community, and dietary supplement manufacturers are “beginning to recognize the potential that choline offers” says an industry expert.

Vitamin Shoppe gets competing bid

10-Sep-2019 By Danielle Masterson

A new player has entered into Vitamin Shoppe negotiations.

GNC teams up with Banco De Franquias to expand presence in Brazil

05-Sep-2019 By Natasha Spencer

Health and wellness brand, GNC Holdings, announced a partnership with professional retail operator, BFG Brasil Comercial de Vitaminas LTDA, to help grow its brand awareness and reputation in Brazil.

Cash crop: Thai authorities approve use of hemp in food, cosmetics and CBD in herbal products

04-Sep-2019 By Tingmin Koe

Hemp and CBD are now allowed for use in herbal products made in Thailand after the authorities relaxed restrictions on their use.

Early CBD player sees sales rise more than 30%

29-Aug-2019 By Hank Schultz

Medical Marijuana Inc, despite its name one of the early players in the hemp/CBD supplement field, has announced sales increases topping 30% and a move to develop products based on additional cannabinoids.

Certified seed shortage means hemp crops exhibit wide range of phytochemistry, expert says

29-Aug-2019 By Hank Schultz

The high variability of hemp plants now being grown in North America means claims of standardization should be take with a grain of salt, a botanical expert says.

Study strengthens supports for lutein-zeaxanthin for cognitive boosts

29-Aug-2019 By Stephen Daniells

Dietary supplementation with lutein, zeaxanthin, and meso-zeaxanthin may boost several parameters of cognitive performance, from attention to memory and processing speed, says a new study.

Editor's Spotlight

CEO refocuses Valensa with ingredient 'platforms' strategy

28-Aug-2019 By Hank Schultz

Fitting a legacy business into the realities of the modern market is a challenge for suppliers of dietary supplement ingredients, according to the CEO of Valensa International.

Despite rising popularity, ayahuasca supplies not imperiled as yet, expert finds

28-Aug-2019 By Hank Schultz

The meteoric rise in the popularity of ayahuasca, a potent brew from the Amazon, has not yet imperiled supplies of the botanical raw materials, according to a report from a noted herbal expert.

Timed release melatonin maker says adverse events data proves product is safe

26-Aug-2019 By Hank Schultz

The manufacturer of a timed-release melatonin product has publicized an additional year of adverse events data which it says bolsters the safety of its product.